Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) today and set a price target of ...

Wells Fargo analyst Yanan Zhu has assigned their bullish stance on ARCT stock, giving a Buy rating on September 19. Yanan Zhu has given his ...

The updated formulation pertains to both approved (Comirnaty and Spikevax) and authorized (Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine) mRNA vaccines. The 2024-2025 mRNA COVID-19 ...

Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of ...

Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

Speaker Mike Johnson is blasting Democrats for being “hypocritical” when it comes to standing with Israel after Iran’s ballistic missile attacks on Tuesday. The GOP leader kicked off a ...

The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...